Healthcare & Pharmaceutical Market Intelligence
Zambia is one of Southern Africa's fastest-emerging pharmaceutical markets, characterized by high import dependency, expanding healthcare access, strong public procurement, and strategic connectivity to neighboring SADC countries.
≈22M
Population (2025)
USD 310M
Pharma Imports
85–95%
Import Dependency
≈USD 400–500M
Pharma Market (2025)
25.7%
National Infertility Burden
Why Zambia?
Where is consumer health growing?
≈USD 400–500M
Pharmaceutical Market (2025)
USD 50–100M
Dietary Supplements Market
7–10%
Supplements Growth Outlook (CAGR)
High
Consumer Demand Outlook
USD 310M Imports • USD 6.47M Exports
National Zambia DHS Evidence
25.7%
Infertility burden among married / cohabiting women aged 18–49
24.4%
Secondary infertility
1.3%
Primary infertility
≈40–50%
Male factor contribution to infertility cases
10–13%
PCOS among women of reproductive age
Sources: 2018 Zambia DHS (7,432 women, published 2026) • Key associated factors: STIs, increasing age, previous abortion, pelvic / abdominal surgery • Infertility prevalence 14%
Where should pharmaceutical companies invest?
Essential medicines: high and consistent demand
Nutraceuticals: rising consumer awareness in urban markets
Women's health: maternal and women's health solutions
Public procurement: the primary market access channel
Regional distribution: gateway to SADC cross-border trade
One of Southern Africa's most import-dependent pharmaceutical markets
Public procurement continues shaping pharmaceutical market growth
Urban healthcare expansion supports long-term consumer health growth
Reproductive healthcare is one of the fastest-growing specialty opportunities
Regional trade corridors strengthen cross-border pharmaceutical distribution
